Hello, everyone, and how are you today? We are just fine, thank you, despite gloomy skies hovering over the sleepy Pharmalot campus. Our spirits remain sunny thanks, in part, to sage advice from the Morning Mayor: “Every brand new day should be unwrapped like a precious gift.” So while you tug on the ribbon, we will indulge in a few more cups of stimulation and continue our quest for items of interest. Speaking of which, here are some tidbits. Hope your day is simply smashing and do drop us a line when interesting developments pop up in your vicinity …

Horizon Pharma (HZNP) has again raised the average wholesale price of Vimovo, a common painkiller combined with a drug that prevents stomach irritation, by 9.9 percent, and a bottle of 60 pills now costs $2,979, The Financial Times writes. Horizon acquired U.S. rights to the medicine in November 2013 from AstraZeneca (AZN), which charged $138 per bottle. Since then, Horizon has raised the price on 11 occasions, including earlier this month, by an aggregate of more than 2,000 percent. If purchased individually, the drugs can cost as little as $36 and both are available in over-the-counter forms.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • A question for our scribe – am I imagining that this sounds like a story once featured in an ancestral version of Pharmalot?

    “A former senior analytical chemist at Merck (MRK) was arrested for stealing and then improperly disposing of 219 grams of potassium cyanide taken from company labs.”

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy